Fig. 3From: LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective studyRepresentative immunohistochemical images of LAG3 expression in MPM. Negative staining (A) and positive staining in infiltrating lymphocytes (B) (20 ×). LAG3 immunohistochemical expression is from our cohort. MPM, malignant pleural mesotheliomaBack to article page